"Hard Science" Provision Likely To Fall From Ag/FDA Appropriations Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
The full House began debate of the FDA funding measure June 14 under a rule that allows the provision to be easily removed.
You may also be interested in...
House Approps Bill Would "Harden" Science Requirements For FDA Rules, Guidance
Provision meant to protect ranchers/farmers could unleash Pandora's box of impediments to regulations, guidance; panel debates Avastin.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.